CN108037221B - Method for simultaneously separating and determining methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography - Google Patents
Method for simultaneously separating and determining methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography Download PDFInfo
- Publication number
- CN108037221B CN108037221B CN201810101645.2A CN201810101645A CN108037221B CN 108037221 B CN108037221 B CN 108037221B CN 201810101645 A CN201810101645 A CN 201810101645A CN 108037221 B CN108037221 B CN 108037221B
- Authority
- CN
- China
- Prior art keywords
- methionine
- solution
- methionine sulfoxide
- methionine sulfone
- reference substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- UCUNFLYVYCGDHP-BYPYZUCNSA-N L-methionine sulfone Chemical compound CS(=O)(=O)CC[C@H](N)C(O)=O UCUNFLYVYCGDHP-BYPYZUCNSA-N 0.000 title claims abstract description 73
- QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical compound C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 title claims abstract description 72
- QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Natural products CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 title claims abstract description 72
- 238000002347 injection Methods 0.000 title claims abstract description 36
- 239000007924 injection Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 29
- 239000012535 impurity Substances 0.000 title claims abstract description 28
- -1 compound amino acid Chemical class 0.000 title claims abstract description 26
- 238000004811 liquid chromatography Methods 0.000 title claims abstract description 6
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 239000000243 solution Substances 0.000 claims description 51
- 239000013558 reference substance Substances 0.000 claims description 35
- 239000012085 test solution Substances 0.000 claims description 27
- 239000011550 stock solution Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 4
- 239000012088 reference solution Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 3
- 229910000388 diammonium phosphate Inorganic materials 0.000 claims description 3
- 238000012417 linear regression Methods 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims 4
- 238000004587 chromatography analysis Methods 0.000 claims 3
- 239000000523 sample Substances 0.000 claims 2
- 239000012488 sample solution Substances 0.000 claims 2
- 238000005303 weighing Methods 0.000 claims 2
- XFXIJSRNFKHZFW-UHFFFAOYSA-N [Na].CCCCCCCC Chemical compound [Na].CCCCCCCC XFXIJSRNFKHZFW-UHFFFAOYSA-N 0.000 claims 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 14
- 238000000926 separation method Methods 0.000 abstract description 6
- 238000004458 analytical method Methods 0.000 abstract description 4
- 239000012071 phase Substances 0.000 description 18
- 239000003814 drug Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- HRQDCDQDOPSGBR-UHFFFAOYSA-M sodium;octane-1-sulfonate Chemical compound [Na+].CCCCCCCCS([O-])(=O)=O HRQDCDQDOPSGBR-UHFFFAOYSA-M 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000019838 diammonium phosphate Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种用液相色谱法同时分离测定复方氨基酸注射液18AA中蛋氨酸亚砜和蛋氨酸砜杂质的方法,所述方法是先将供试品溶液在高效液相色谱仪中测定,再按照标准曲线法以峰面积计算供试品中蛋氨酸亚砜和蛋氨酸砜杂质的含量。本发明的检测方法简便可行,分析时间短,专属性强,重现性好,可以有效测定及分离复方氨基酸注射液18AA中的蛋氨酸亚砜和蛋氨酸砜杂质。
The invention discloses a method for simultaneous separation and determination of methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography. According to the standard curve method, the content of methionine sulfoxide and methionine sulfone impurities in the test sample was calculated by peak area. The detection method of the invention is simple and feasible, has short analysis time, strong specificity and good reproducibility, and can effectively measure and separate the methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA.
Description
技术领域technical field
本发明属于药物质量测定方法技术领域,尤其涉及一种用高效液相色谱仪分离检测复方氨基酸注射液18AA中甲硫氨酸降解杂质蛋氨酸亚砜和蛋氨酸砜的方法。The invention belongs to the technical field of drug quality determination methods, in particular to a method for separating and detecting methionine in compound amino acid injection 18AA to degrade impurities of methionine sulfoxide and methionine sulfone by high performance liquid chromatography.
背景技术Background technique
复方氨基酸注射液18AA主要用于蛋白质摄入不足、吸收障碍等氨基酸不能满足机体代谢需要的患者,亦用于改善手术后病人的营养状况。复方氨基酸注射液的飞速发展使得临床危重症患者得到良好的肠外营养支持,保证了机体的正氮平衡,促进了蛋白质的合成。Compound Amino Acid Injection 18AA is mainly used for patients with insufficient protein intake, malabsorption and other amino acids that cannot meet the metabolic needs of the body. It is also used to improve the nutritional status of patients after surgery. The rapid development of compound amino acid injection enables clinical critically ill patients to receive good parenteral nutrition support, ensures the body's positive nitrogen balance, and promotes protein synthesis.
随着公众和媒体对药品安全性的日益关注,药品中的杂质已成为药品质量控制中的重要指标。近年来,随着新的分析检测技术的问世和推广,药物中微量的有害物质正逐渐被阐明揭示其化学结构或物质基础,在杂质的安全性研究上也涌现了一些快速筛选平台,为今后产品的质量控制奠定了基础。将杂质水平与药物安全性的关联性研究透彻,这也是今后研究的方向之一。With the increasing public and media attention to drug safety, impurities in drugs have become an important indicator in drug quality control. In recent years, with the advent and promotion of new analysis and detection technologies, trace amounts of harmful substances in medicines are gradually being elucidated to reveal their chemical structures or material basis, and some rapid screening platforms have also emerged in the safety research of impurities. The quality control of the product lays the foundation. Thorough research on the relationship between impurity levels and drug safety is also one of the directions for future research.
由于缺乏发色团,氨基酸的纯度评估工作一直是个难题。在过去的欧洲药典中,氨基酸原料的杂质监控通常借助于茚三酮试剂显色的薄层色谱法,然而该方法的灵敏度和性能较差。在新版欧洲药典中氨基酸的杂质检验变更为离子交换柱后茚三酮衍生反应的分析方法(EDQM,European Pharmacopoeia 8th Edition,2015)。Due to the lack of chromophores, the purity assessment of amino acids has been difficult. In the past European Pharmacopoeia, the impurity monitoring of amino acid raw materials usually resorted to thin-layer chromatography with ninhydrin reagent color development, however, the sensitivity and performance of this method were poor. In the new version of the European Pharmacopoeia, the impurity test of amino acids was changed to the analytical method of ninhydrin derivatization after ion exchange column (EDQM, European Pharmacopoeia 8th Edition, 2015).
蛋氨酸亚砜是甲硫氨酸的氧化杂质,对男性肝细胞具有一定的毒性损伤作用。蛋氨酸砜也是甲硫氨酸的氧化杂质,能够抑制谷氨酸的生物合成。Methionine sulfoxide is an oxidized impurity of methionine, which has certain toxic and damaging effects on male hepatocytes. Methionine sulfone is also an oxidized impurity of methionine and can inhibit glutamate biosynthesis.
蛋氨酸亚砜和蛋氨酸砜两个杂质的存在对复方氨基酸注射液18AA的临床用药安全构成了潜在的威胁。然而,通过文献检索,同时分离检测复方氨基酸注射液18AA中的蛋氨酸亚砜和蛋氨酸砜杂质的检测方法并未见相关报道。The existence of two impurities, methionine sulfoxide and methionine sulfone, poses a potential threat to the clinical safety of compound amino acid injection 18AA. However, through literature search, there is no relevant report on the simultaneous separation and detection of methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA.
因此,需要一种科学、有效的同时分离测定复方氨基酸注射液18AA中蛋氨酸亚砜和蛋氨酸砜杂质的方法,既可以降低检测成本、减轻劳动强度又节能环保。Therefore, a scientific and effective method for simultaneous separation and determination of methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA is needed, which can not only reduce the detection cost, reduce labor intensity, but also save energy and protect the environment.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种用液相色谱法同时分离测定复方氨基酸注射液18AA中蛋氨酸亚砜和蛋氨酸砜杂质的方法。The object of the present invention is to provide a method for simultaneously separating and measuring methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography.
为实现上述目的,本发明采用以下内容:To achieve the above object, the present invention adopts the following content:
一种用液相色谱法同时分离测定复方氨基酸注射液18AA中蛋氨酸亚砜和蛋氨酸砜杂质的方法,所述方法是先将供试品溶液在高效液相色谱仪中测定,再按照标准曲线法以峰面积计算供试品中蛋氨酸亚砜和蛋氨酸砜杂质的含量;A method for simultaneously separating and measuring methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography. Calculate the content of methionine sulfoxide and methionine sulfone impurities in the test sample by peak area;
色谱条件为:The chromatographic conditions are:
色谱柱为十八烷基硅烷键合硅胶色谱柱;The chromatographic column is an octadecylsilane-bonded silica gel chromatographic column;
流动相A为0.01mol·L-1磷酸氢二铵溶液,其中含0.01mol·L-1辛烷磺酸钠缓冲溶液,用磷酸调节pH值至1.9±0.05;Mobile phase A is 0.01mol·L -1 diammonium hydrogen phosphate solution, which contains 0.01mol·L -1 sodium octane sulfonate buffer solution, and the pH value is adjusted to 1.9±0.05 with phosphoric acid;
流动相B为乙腈;Mobile phase B is acetonitrile;
流动相洗脱程序:Mobile phase elution procedure:
流速为每分钟1.0ml;The flow rate is 1.0ml per minute;
检测波长为205nm;The detection wavelength is 205nm;
柱温为4℃;The column temperature is 4°C;
进样体积为100μl。The injection volume was 100 μl.
进一步地,所述色谱柱为Titank C18色谱柱;所述Titank C18色谱柱的规格为4.6mm×250mm,5μm。Further, the chromatographic column is a Titank C18 chromatographic column; the specification of the Titank C18 chromatographic column is 4.6 mm×250 mm, 5 μm.
进一步地,所述方法中,供试品溶液是:取蛋氨酸亚砜对照品,精密称定,用水溶解并定量稀释制成每1ml中约含蛋氨酸亚砜1mg的对照品溶液,作为蛋氨酸亚砜对照品贮备液;取蛋氨酸砜对照品,精密称定,用水溶解并定量稀释制成每1ml中约含蛋氨酸砜1mg的对照品溶液,作为蛋氨酸砜对照品贮备液;分别精密量取复方氨基酸注射液18AA、蛋氨酸亚砜对照品贮备液、蛋氨酸砜对照品贮备液各1ml,混合置于10ml量瓶中,加水稀释至刻度,摇匀,作为供试品溶液。Further, in the described method, the need testing solution is: take the methionine sulfoxide reference substance, accurately weigh it, dissolve in water and quantitatively dilute to make a reference substance solution containing about 1mg of methionine sulfoxide in every 1ml, as methionine sulfoxide. Reference substance stock solution; take the methionine sulfone reference substance, accurately weigh it, dissolve it in water and quantitatively dilute it to make a reference substance solution containing about 1 mg of methionine sulfone per 1 ml, as the methionine sulfone reference substance stock solution; respectively accurately measure the compound amino acid for injection Liquid 18AA, methionine sulfoxide reference substance stock solution, methionine sulfone reference substance stock solution, 1ml each, mixed and placed in a 10ml volumetric flask, diluted with water to the mark, shaken up, and used as the test solution.
进一步地,所述方法中,制备对照溶液,利用高效液相色谱仪对对照溶液进行检测,以峰面积为纵坐标,进样浓度为横坐标,进行线性回归,绘制标准曲线并得到回归方程;所述制备对照溶液是:精密量取蛋氨酸亚砜对照品贮备液适量,用水稀释,分别制成每1ml中约含蛋氨酸亚砜0.30、5、10、50、100和200μg的溶液,作为蛋氨酸亚砜对照溶液;精密量取蛋氨酸砜对照品贮备液适量,用水稀释,分别制成每1ml中约含蛋氨酸砜4.20、5、10、50、100和200μg的溶液,作为蛋氨酸砜对照溶液。Further, in the method, a reference solution is prepared, and a high performance liquid chromatograph is used to detect the reference solution, taking the peak area as the ordinate and the injection concentration as the abscissa, performing linear regression, drawing a standard curve and obtaining a regression equation; The preparation of the control solution is as follows: accurately measure an appropriate amount of the methionine sulfoxide reference substance stock solution, dilute with water, and prepare solutions containing about 0.30, 5, 10, 50, 100 and 200 μg of methionine sulfoxide per 1 ml, respectively, as methionine sulfoxide. Sulfone reference solution: Precisely measure an appropriate amount of the methionine sulfone reference stock solution, dilute it with water, and prepare solutions containing about 4.20, 5, 10, 50, 100 and 200 μg of methionine sulfone per 1 ml, respectively, as the methionine sulfone control solution.
本发明具有以下优点:The present invention has the following advantages:
本发明的检测方法简便可行,分析时间短,专属性强,重现性好,可以在35分钟内同时分离复方氨基酸注射液18AA中的蛋氨酸亚砜和蛋氨酸砜杂质并进行检测,提供了现有技术未能解决的分离测定问题,从而确保复方氨基酸注射液18AA的质量可控,并最终确定产品的安全有效。The detection method of the invention is simple and feasible, the analysis time is short, the specificity is strong, and the reproducibility is good, and the methionine sulfoxide and methionine sulfone impurities in the compound amino acid injection 18AA can be simultaneously separated and detected within 35 minutes, and the existing method is provided. The separation and determination problems that cannot be solved by the technology, so as to ensure the controllable quality of compound amino acid injection 18AA, and finally determine the safety and effectiveness of the product.
附图说明Description of drawings
图1是复方氨基酸注射液18AA的色谱图。Fig. 1 is the chromatogram of compound amino acid injection 18AA.
图2是供试品溶液的色谱图。Figure 2 is the chromatogram of the test solution.
图3是蛋氨酸亚砜线性对照溶液(5)的色谱图。Figure 3 is a chromatogram of a methionine sulfoxide linear control solution (5).
图4是蛋氨酸砜线性对照溶液(5)的色谱图。Figure 4 is a chromatogram of a methionine sulfone linear control solution (5).
图5是蛋氨酸亚砜线性曲线图。Figure 5 is a linear graph of methionine sulfoxide.
图6是蛋氨酸砜线性曲线图。Figure 6 is a linear graph of methionine sulfone.
图7是正常条件下供试品溶液的色谱图。Figure 7 is the chromatogram of the test solution under normal conditions.
图8是流速+10%条件下供试品溶液的色谱图。Figure 8 is the chromatogram of the test solution under the condition of flow rate + 10%.
图9是流速-10%条件下供试品溶液的色谱图。Figure 9 is the chromatogram of the test solution under the condition of flow rate -10%.
图10是有机相比例+1%条件下供试品溶液的色谱图。Figure 10 is the chromatogram of the test solution under the condition of organic phase ratio + 1%.
图11是有机相比例-1%条件下供试品溶液的色谱图。Figure 11 is the chromatogram of the test solution under the condition of organic phase ratio-1%.
图12是流动相pH值+0.05条件下供试品溶液的色谱图。Figure 12 is the chromatogram of the test solution under the condition of mobile phase pH value + 0.05.
图13是流动相pH值-0.05条件下供试品溶液的色谱图。Figure 13 is the chromatogram of the test solution under the condition of mobile phase pH value -0.05.
具体实施方式Detailed ways
为了更清楚地说明本发明,下面结合优选实施例对本发明做进一步的说明。本领域技术人员应当理解,下面所具体描述的内容是说明性的而非限制性的,不应以此限制本发明的保护范围。In order to illustrate the present invention more clearly, the present invention will be further described below with reference to the preferred embodiments. Those skilled in the art should understand that the content specifically described below is illustrative rather than restrictive, and should not limit the protection scope of the present invention.
本发明具体实施方式中使用的试剂、药品、仪器设备均为已知产品,均可以通过购买市售产品获得。具体如下:The reagents, medicines, instruments and equipment used in the specific embodiments of the present invention are all known products and can be obtained by purchasing commercially available products. details as follows:
试剂与药品:Reagents and Medicines:
蛋氨酸亚砜对照品(arkpharminc,批号:WG0002486-160825001);蛋氨酸砜对照品(北京百灵威科技有限公司,批号:LCC0Q84);Methionine sulfoxide reference substance (arkpharminc, batch number: WG0002486-160825001); methionine sulfone reference substance (Beijing Bailingwei Technology Co., Ltd., batch number: LCC0Q84);
复方氨基酸注射液(18AA)(辰欣药业股份有限公司,批号:1611052143);Compound amino acid injection (18AA) (Chenxin Pharmaceutical Co., Ltd., batch number: 1611052143);
乙腈(TEDIA,批号:AS1122-801)为色谱纯;Acetonitrile (TEDIA, batch number: AS1122-801) is chromatographically pure;
磷酸氢二胺(国药集团化学试剂有限公司,批号:20170301)Diamine hydrogen phosphate (Sinopharm Chemical Reagent Co., Ltd., batch number: 20170301)
辛烷磺酸钠(萨恩化学技术上海有限公司,批号:EI050108)为分析纯。Sodium octane sulfonate (Sahn Chemical Technology Shanghai Co., Ltd., batch number: EI050108) was of analytical grade.
仪器设备:equipment:
Waters1525高效液相色谱仪;Waters1525 high performance liquid chromatograph;
上海雷磁台式精密数显PHS-3G酸度计;Shanghai Lei magnetic desktop precision digital display PHS-3G acidity meter;
十万分之一精密电子天平型号:AUW220D;1/100,000 precision electronic balance model: AUW220D;
循环水真空泵型号:SHB-Ⅲ。Circulating water vacuum pump model: SHB-Ⅲ.
实施例1Example 1
一种用液相色谱法同时分离测定复方氨基酸注射液18AA中蛋氨酸亚砜和蛋氨酸砜杂质的方法,包括以下步骤:A method for simultaneously separating and measuring methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography, comprising the following steps:
1)制备对照品贮备液:1) Prepare reference stock solution:
取蛋氨酸亚砜对照品,精密称定,用水溶解并定量稀释制成每1ml中约含蛋氨酸亚砜1mg的对照品溶液,作为蛋氨酸亚砜对照品贮备液。Take the methionine sulfoxide reference substance, accurately weigh it, dissolve it in water and quantitatively dilute it to prepare a reference substance solution containing about 1 mg of methionine sulfoxide per 1 ml, as the methionine sulfoxide reference substance stock solution.
取蛋氨酸砜对照品,精密称定,用水溶解并定量稀释制成每1ml中约含蛋氨酸砜1mg的对照品溶液,作为蛋氨酸砜对照品贮备液。Take the methionine sulfone reference substance, accurately weigh it, dissolve it in water and quantitatively dilute it to make a reference substance solution containing about 1 mg of methionine sulfone per 1 ml, as the methionine sulfone reference substance stock solution.
2)制备对照溶液2) Prepare control solution
精密量取蛋氨酸亚砜对照品贮备液适量,用水稀释,分别制成每1ml中约含蛋氨酸亚砜0.30、5、10、50、100和200μg的溶液,作为蛋氨酸亚砜对照溶液(1)、(2)、(3)、(4)、(5)和(6)。Precisely measure an appropriate amount of methionine sulfoxide reference substance stock solution, dilute with water, and prepare solutions containing about 0.30, 5, 10, 50, 100, and 200 μg of methionine sulfoxide per 1 ml, respectively, as methionine sulfoxide control solution (1), (2), (3), (4), (5) and (6).
精密量取蛋氨酸砜对照品贮备液适量,用水稀释,分别制成每1ml中约含蛋氨酸砜4.20、5、10、50、100和200μg的溶液,作为蛋氨酸砜对照溶液(1)、(2)、(3)、(4)、(5)和(6)。Precisely measure an appropriate amount of methionine sulfone reference stock solution, dilute with water, and prepare solutions containing about 4.20, 5, 10, 50, 100, and 200 μg of methionine sulfone per 1 ml, respectively, as methionine sulfone control solutions (1), (2) , (3), (4), (5) and (6).
3)制备供试品溶液3) Prepare the test solution
由于复方氨基酸注射液18AA样品中本身蛋氨酸亚砜和蛋氨酸砜两个杂质的含量非常小,不便于色谱条件的探索,为了便于考察色谱条件,供试品溶液按照如下方式配制:Since the content of two impurities, methionine sulfoxide and methionine sulfone, in the compound amino acid injection 18AA sample is very small, it is not convenient to explore the chromatographic conditions. In order to facilitate the investigation of the chromatographic conditions, the test solution was prepared as follows:
分别精密量取复方氨基酸注射液18AA、蛋氨酸亚砜对照品贮备液、蛋氨酸砜对照品贮备液各1ml,混合置于10ml量瓶中,加水稀释至刻度,摇匀,作为供试品溶液。Precisely measure 1ml each of Compound Amino Acid Injection 18AA, methionine sulfoxide reference substance stock solution, and methionine sulfone reference substance stock solution, mix them in a 10ml measuring bottle, add water to dilute to the mark, shake well, and use as the test solution.
4)测定4) Determination
分别取蛋氨酸亚砜线性对照溶液(1)~(6)、蛋氨酸砜线性对照溶液(1)~(6)和供试品溶液各100μl注入高效液相色谱仪,记录色谱图。典型图谱如图1~4所示。Take methionine sulfoxide linear control solution (1)-(6), methionine sulfone linear control solution (1)-(6) and test solution, respectively, inject 100 μl into high performance liquid chromatograph, and record the chromatogram. Typical spectra are shown in Figures 1-4.
色谱条件为:The chromatographic conditions are:
色谱柱:Titank C18,4.6mm×250mm,5μm;Chromatographic column: Titank C18, 4.6mm×250mm, 5μm;
流动相A为0.01mol·L-1磷酸氢二铵溶液,其中含0.01mol·L-1辛烷磺酸钠缓冲溶液,用磷酸调节pH值至1.9±0.05;Mobile phase A is 0.01mol·L -1 diammonium hydrogen phosphate solution, which contains 0.01mol·L -1 sodium octane sulfonate buffer solution, and the pH value is adjusted to 1.9±0.05 with phosphoric acid;
流动相B:乙腈;Mobile phase B: acetonitrile;
按表1进行线性梯度洗脱,流速为每分钟1.0ml;Carry out linear gradient elution according to Table 1, the flow rate is 1.0ml per minute;
检测波长:205nm;Detection wavelength: 205nm;
柱温:4℃;Column temperature: 4℃;
进样体积:100μl。Injection volume: 100 μl.
表1梯度洗脱程序Table 1 Gradient elution procedure
图2中,保留时间为14.780分钟的为蛋氨酸亚砜,保留时间为16.465分钟的为蛋氨酸砜。蛋氨酸砜与蛋氨酸亚砜之间的分离度为1.8,且蛋氨酸砜与相邻峰、蛋氨酸亚砜与相邻峰均分离良好,图2说明在此条件下可以实现本发明的发明目的。In Figure 2, the retention time of 14.780 minutes is methionine sulfoxide, and the retention time of 16.465 minutes is methionine sulfone. The degree of separation between methionine sulfone and methionine sulfoxide is 1.8, and methionine sulfone and adjacent peaks and methionine sulfoxide and adjacent peaks are well separated. Figure 2 shows that the object of the present invention can be achieved under this condition.
实施例2(线性范围)Example 2 (Linear Range)
按照实施例1中蛋氨酸亚砜对照溶液和蛋氨酸砜对照溶液的配制方法,分别配制蛋氨酸亚砜对照溶液(1)、(2)、(3)、(4)、(5)和(6)以及蛋氨酸砜对照溶液(1)、(2)、(3)、(4)、(5)和(6)。According to the preparation method of the methionine sulfoxide control solution and the methionine sulfone control solution in Example 1, the methionine sulfoxide control solutions (1), (2), (3), (4), (5) and (6) and Methionine sulfone control solutions (1), (2), (3), (4), (5) and (6).
精密量取蛋氨酸亚砜对照溶液(1)、(2)、(3)、(4)、(5)和(6)以及蛋氨酸砜对照溶液(1)、(2)、(3)、(4)、(5)和(6)各100μl,分别注入高效液相色谱仪中,记录色谱图,量取峰面积。以峰面积A为纵坐标,进样浓度C为横坐标,进行线性回归,并计算相关系数(r)。Precisely measure methionine sulfoxide control solutions (1), (2), (3), (4), (5) and (6) and methionine sulfone control solutions (1), (2), (3), (4 ), (5) and (6), 100 μl each, respectively, were injected into the high performance liquid chromatograph, the chromatogram was recorded, and the peak area was measured. Take the peak area A as the ordinate and the injection concentration C as the abscissa, perform linear regression, and calculate the correlation coefficient (r).
表2蛋氨酸亚砜线性与范围试验结果Table 2 methionine sulfoxide linearity and range test results
表3蛋氨酸砜线性与范围试验结果Table 3 methionine sulfone linearity and range test results
结果表明,蛋氨酸亚砜在0.31~201.76μg·ml-1的浓度范围内,线性曲线为A=44217C-3774,r=1(详见表2、图5)。蛋氨酸砜在4.51~225.72μg·ml-1的浓度范围内,线性曲线为A=2618C-1360,r=0.9999(详见表3、图6)。蛋氨酸亚砜、蛋氨酸砜进样浓度与各自对应的峰面积响应值呈显著的线性关系。The results showed that methionine sulfoxide was in the concentration range of 0.31-201.76 μg·ml -1 , and the linear curve was A=44217C-3774, r=1 (see Table 2 and Figure 5 for details). In the concentration range of methionine sulfone from 4.51 to 225.72 μg·ml -1 , the linear curve was A=2618C-1360, r=0.9999 (see Table 3 and Figure 6 for details). There was a significant linear relationship between the injection concentrations of methionine sulfoxide and methionine sulfone and their corresponding peak area response values.
实施例3(精密度)Example 3 (precision)
1、进样精密度:1. Injection precision:
精密量取蛋氨酸亚砜对照品贮备液适量,用水稀释,制成每1ml中约含蛋氨酸亚砜10μg的溶液,在实施例1的色谱条件下,连续进样6次,蛋氨酸亚砜峰面积的RSD为0.16%(表4)。Precisely measure an appropriate amount of methionine sulfoxide reference substance stock solution, dilute it with water, and prepare a solution containing about 10 μg of methionine sulfoxide per 1 ml. The RSD was 0.16% (Table 4).
精密量取蛋氨酸砜对照品贮备液适量,用水稀释,制成每1ml中约含蛋氨酸砜10μg的溶液,在实施例1的色谱条件下,连续进样6次,蛋氨酸砜峰面积的RSD为1.84%(表5)。由表4和表5可知,重复性良好。Precisely measure an appropriate amount of the methionine sulfone reference stock solution, dilute with water, and prepare a solution containing about 10 μg of methionine sulfone per 1 ml. Under the chromatographic conditions of Example 1, continuous injections were carried out 6 times, and the RSD of the peak area of methionine sulfone was 1.84. %(table 5). As can be seen from Tables 4 and 5, the repeatability was good.
表4蛋氨酸亚砜线性与范围试验结果Table 4 methionine sulfoxide linearity and range test results
表5蛋氨酸砜线性与范围试验结果Table 5 methionine sulfone linearity and range test results
2、重复性试验:2. Repeatability test:
按照实施例1中的方法平行配制6份供试品溶液。精密量取6份供试品溶液、蛋氨酸亚砜对照溶液(1)、(2)、(3)、(4)、(5)和(6)以及蛋氨酸砜对照溶液(1)、(2)、(3)、(4)、(5)和(6),并分别进行进样分析,测得蛋氨酸亚砜平均含量为1003.1μg·ml-1,RSD为0.13%;蛋氨酸砜平均含量为1182.4μg·ml-1,RSD为1.41%(详见表6)。数据结果表明本法重复性良好。According to the method in Example 1, 6 parts of the test solution were prepared in parallel. Precisely measure 6 parts of the test solution, methionine sulfoxide control solution (1), (2), (3), (4), (5) and (6) and methionine sulfone control solution (1), (2) , (3), (4), (5) and (6), and analyzed by sample injection respectively, the average content of methionine sulfoxide was 1003.1 μg·ml -1 , the RSD was 0.13%; the average content of methionine sulfone was 1182.4 μg·ml -1 , the RSD was 1.41% (see Table 6 for details). The data results show that the method has good repeatability.
表6重复性实验结果Table 6 Repeated experimental results
实施例4(溶液稳定性实验)Example 4 (solution stability test)
将供试品溶液室温放置,分别于0、3、6、10、14、17、20、24小时后测定,进样体积为100μl,用供试品溶液的主峰面积和杂质含量考察供试品溶液的稳定性。实验结果见表7:The test solution was placed at room temperature, and measured after 0, 3, 6, 10, 14, 17, 20, and 24 hours, respectively. The injection volume was 100 μl. The main peak area and impurity content of the test solution were used to investigate the test. solution stability. The experimental results are shown in Table 7:
表7供试品溶液稳定性实验结果Table 7 Test results for the stability of the test solution
由表7可知,供试品溶液在室温放置24小时内是稳定的。It can be seen from Table 7 that the test solution is stable within 24 hours at room temperature.
实施例5(准确度:加样回收率实验)Example 5 (accuracy: sample recovery experiment)
溶液的配制:Preparation of the solution:
取蛋氨酸亚砜(MetsoX)对照品,精密称定,用水溶解并定量稀释制成每1ml中约含蛋氨酸亚砜1mg的对照品溶液,作为蛋氨酸亚砜对照品贮备液。Take the methionine sulfoxide (MetsoX) reference substance, accurately weigh it, dissolve it in water and quantitatively dilute it to prepare a reference substance solution containing about 1 mg of methionine sulfoxide per 1 ml, as the methionine sulfoxide reference substance stock solution.
取蛋氨酸砜(MetsoN)对照品,精密称定,用水溶解并定量稀释制成每1ml中约含蛋氨酸砜1mg的对照品溶液,作为蛋氨酸砜对照品贮备液。Take the methionine sulfone (MetsoN) reference substance, accurately weigh it, dissolve it in water and quantitatively dilute it to make a reference substance solution containing about 1 mg of methionine sulfone per 1 ml, as the methionine sulfone reference substance stock solution.
按照实施例1中的方法分别配制蛋氨酸亚砜对照溶液(1)、(2)、(3)、(4)、(5)、(6)以及蛋氨酸砜对照溶液(1)、(2)、(3)、(4)、(5)、(6)。According to the method in Example 1, respectively prepare methionine sulfoxide control solutions (1), (2), (3), (4), (5), (6) and methionine sulfone control solutions (1), (2), (3), (4), (5), (6).
分别向复方氨基酸注射液(18AA)中加入50μg·ml-1、100μg·ml-1、1000μg·ml-1的蛋氨酸亚砜、蛋氨酸砜(具体配制方法如下:精密量取复方氨基酸注射液(18AA)1ml,置10ml量瓶中,分别向其中加入浓度约为50μg·ml-1、100μg·ml-1、1000μg·ml-1的蛋氨酸亚砜和蛋氨酸砜溶液各1ml),每个浓度点平行配制3份溶液,按照实施例1的测定方法,对上述各杂质的含量予以测定。计算各杂质的加样回收率及其RSD。回收率结果见表8。Add 50μg·ml -1 , 100μg·ml -1 , 1000μg·ml -1 of methionine sulfoxide and methionine sulfone to compound amino acid injection (18AA) respectively (the specific preparation method is as follows: Precisely measure compound amino acid injection (18AA). ) 1ml, put it in a 10ml volumetric flask, add 1ml of methionine sulfoxide and methionine sulfone solutions with concentrations of about 50μg·ml -1 , 100μg·ml -1 , 1000μg·ml -1 respectively), each concentration point is parallel Three solutions were prepared, and the content of each of the above impurities was measured according to the measurement method of Example 1. Calculate the sample recovery and RSD of each impurity. The recovery results are shown in Table 8.
表8加样回收率试验结果(n=9)Table 8 Test results of sample addition recovery rate (n=9)
由表8可知,本方法中蛋氨酸亚砜(MetsoX)和蛋氨酸砜(MetsoN)的回收率分别在99.09~102.14%、98.20~101.21%之间,测定准确性良好。It can be seen from Table 8 that the recoveries of methionine sulfoxide (MetsoX) and methionine sulfone (MetsoN) in this method are respectively 99.09-102.14% and 98.20-101.21%, and the measurement accuracy is good.
实施例6(耐用性试验)Example 6 (durability test)
适当调节流动相的流速、流动相pH值以及有机相比例,将实施例1中的色谱条件进行较小幅度的变动,对比不同条件下同一样品中蛋氨酸亚砜和蛋氨酸砜的测定结果,对该色谱条件的耐用性进行考察,结果见表9,色谱图见图7~图13。Appropriately adjust the flow rate of the mobile phase, the pH value of the mobile phase and the proportion of the organic phase, change the chromatographic conditions in Example 1 to a small extent, and compare the measurement results of methionine sulfoxide and methionine sulfone in the same sample under different conditions. The durability of the chromatographic conditions was investigated, the results are shown in Table 9, and the chromatograms are shown in Figures 7 to 13.
图7是正常条件下供试品溶液的色谱图。图8是流速+10%条件下供试品溶液的色谱图。图9是流速-10%条件下供试品溶液的色谱图。图10是有机相比例+1%条件下供试品溶液的色谱图。图11是有机相比例-1%条件下供试品溶液的色谱图。图12是流动相pH值+0.05条件下供试品溶液的色谱图。图13是流动相pH值-0.05条件下供试品溶液的色谱图。Figure 7 is the chromatogram of the test solution under normal conditions. Figure 8 is the chromatogram of the test solution under the condition of flow rate + 10%. Figure 9 is the chromatogram of the test solution under the condition of flow rate -10%. Figure 10 is the chromatogram of the test solution under the condition of organic phase ratio + 1%. Figure 11 is the chromatogram of the test solution under the condition of organic phase ratio-1%. Figure 12 is the chromatogram of the test solution under the condition of mobile phase pH value + 0.05. Figure 13 is the chromatogram of the test solution under the condition of mobile phase pH value -0.05.
表9耐用性实验结果Table 9 Durability test results
注:-a:色谱图中未显示出其分离度情况。Note:- a : The resolution is not shown in the chromatogram.
从表9中可知,以流动相的流速、缓冲盐pH值、以及流动相组成比例作微小改变后,有机相比例+1%条件下,蛋氨酸亚砜(MetsoX)和蛋氨酸砜(MetsoN)分别与相邻峰重叠在一起没有分离。其余几种条件下蛋氨酸亚砜(MetsoX)和蛋氨酸砜(MetsoN)保留时间虽有微小变动,但测定结果基本一致,有关物质测定耐用性良好。因此,实验过程中需严格控制有机相的比例在规定的范围内变动。It can be seen from Table 9 that after slight changes in the flow rate of the mobile phase, the pH value of the buffer salt, and the composition ratio of the mobile phase, under the condition of organic phase ratio + 1%, methionine sulfoxide (MetsoX) and methionine sulfone (MetsoN) were Adjacent peaks overlap without separation. Although the retention time of methionine sulfoxide (MetsoX) and methionine sulfone (MetsoN) changed slightly under the other conditions, the determination results were basically the same, and the determination durability of related substances was good. Therefore, it is necessary to strictly control the proportion of the organic phase to change within the specified range during the experiment.
本发明的检测方法使用酸性离子对试剂及有机溶剂为流动相,并采用高效液相色谱法分离测定复方氨基酸注射液18AA中的蛋氨酸亚砜和蛋氨酸砜杂质,可以在35分钟内同时分离蛋氨酸亚砜和蛋氨酸砜杂质并进行检测,对于复方氨基酸注射液18AA药物的质量控制及氨基酸降解途径的研究十分有意义。The detection method of the present invention uses acidic ion pair reagent and organic solvent as mobile phases, and adopts high performance liquid chromatography to separate and measure methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA, and can simultaneously separate methionine sulfoxide within 35 minutes. The detection of sulfone and methionine sulfone impurities is very meaningful for the quality control of compound amino acid injection 18AA and the research on amino acid degradation pathway.
显然,本发明的上述实施例仅仅是为清楚地说明本发明所作的举例,而并非是对本发明的实施方式的限定,对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动,这里无法对所有的实施方式予以穷举,凡是属于本发明的技术方案所引伸出的显而易见的变化或变动仍处于本发明的保护范围之列。Obviously, the above-mentioned embodiments of the present invention are only examples for clearly illustrating the present invention, rather than limiting the embodiments of the present invention. Changes or changes in other different forms cannot be exhausted here, and all obvious changes or changes derived from the technical solutions of the present invention are still within the protection scope of the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810101645.2A CN108037221B (en) | 2018-02-01 | 2018-02-01 | Method for simultaneously separating and determining methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810101645.2A CN108037221B (en) | 2018-02-01 | 2018-02-01 | Method for simultaneously separating and determining methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108037221A CN108037221A (en) | 2018-05-15 |
CN108037221B true CN108037221B (en) | 2020-11-17 |
Family
ID=62097108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810101645.2A Expired - Fee Related CN108037221B (en) | 2018-02-01 | 2018-02-01 | Method for simultaneously separating and determining methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108037221B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112697934A (en) * | 2020-12-10 | 2021-04-23 | 武汉久安药业有限公司 | Method for detecting content of pyroglutamic acid in compound amino acid injection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106248853A (en) * | 2016-08-30 | 2016-12-21 | 四川科伦药业股份有限公司 | Method for determining content of degraded impurity methionine sulfoxide in compound amino acid injection |
CN106841408A (en) * | 2015-12-03 | 2017-06-13 | 华仁药业股份有限公司 | The method for quick of methionine sulfoxide in a kind of amino acid injection |
-
2018
- 2018-02-01 CN CN201810101645.2A patent/CN108037221B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106841408A (en) * | 2015-12-03 | 2017-06-13 | 华仁药业股份有限公司 | The method for quick of methionine sulfoxide in a kind of amino acid injection |
CN106248853A (en) * | 2016-08-30 | 2016-12-21 | 四川科伦药业股份有限公司 | Method for determining content of degraded impurity methionine sulfoxide in compound amino acid injection |
Non-Patent Citations (7)
Title |
---|
A HIGH PRESSURE LIQUID CHROMATOGRAPHIC METHOD FOR DETERMINING THE STABILITY OF FREE METHIONINE IN METHIONINE-FORTIFIED FOOD SYSTEMS;L. S. O’ KEEFE等;《JURNAL OF FOOD SCIENCE》;19781231(第43期);第1297-1300页 * |
Analysis of natural and modified amino acidsand hexosamines by reversed-phase high-performance liquid chrornatoqraphv;REKHA GUPTA等;《Journal of Chromatography》;19891231(第474期);第411-417页 * |
Convenient method of threonine, methionine and their related amino compounds by high-performance liquid chromatography and its application to rumen fluid;Mamun M.Or-Rashid等;《Journal of Chromatography B》;20001231(第741期);第279-287页 * |
Determination of methionine sulfoxide in biological materials using HPLC and its degradability in the rumen of cattle;R. Puchata等;《Animal Feed Science and Technology》;19941231(第48期);第121-130页 * |
METHIONINE STABILITY IN METHIONINE-FORTIFIED MODEL FOOD SYSTEMS AS INFLUENCED BY METHOD OF METHIONINE INCORPORATION AND BY LIPID OXIDATION;M. C. TUFTE等;《JURNAL OF FOOD SCIENCE》;19791231(第44期);第1767-1771页 * |
用日立L-8500氨基酸分析仪测定明胶中的蛋氨酸、蛋氨酸矾及蛋氨酸亚砜;肖玉霞等;《氨基酸杂志》;19941231(第1期);第31-35页 * |
高压液相色谱检侧明胶中的蛋氨酸亚砜;李河冰;《明胶科学与技术》;19991231;第19卷(第4期);第179-182页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108037221A (en) | 2018-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Maráková et al. | Simultaneous determination of twelve biogenic amines in human urine as potential biomarkers of inflammatory bowel diseases by capillary electrophoresis–tandem mass spectrometry | |
CN107991415B (en) | Simultaneous separation and determination of pyroglutamic acid and methionine sulfoxide impurities in compound amino acid injection 18AA by liquid chromatography | |
Wen et al. | Development and validation of a hydrophilic interaction ultra‐high‐performance liquid chromatography–tandem mass spectrometry method for rapid simultaneous determination of 19 free amino acids in rat plasma and urine | |
CN108663448A (en) | Detection method in relation to substance in a kind of Amino Acid Compound Injection | |
CN110031557A (en) | The detection method of 5- isoquinolin methylmesylate, 5- isoquinolin sulfonic acid in a kind of Fasudic hydrochloride | |
CN115356420A (en) | Pudilan anti-inflammatory tablet quality evaluation method based on one-test-multiple evaluation | |
Zhang et al. | Evaluation of the oxidative deoxyribonucleic acid damage biomarker 8-hydroxy-2′-deoxyguanosine in the urine of leukemic children by micellar electrokinetic capillary chromatography | |
CN106841408B (en) | The rapid detection method of methionine sulfoxide in a kind of amino acid injection | |
CN106596771B (en) | A method of beta-hydroxy-Beta-methyl butyric acid content in measurement soybean peptide protein powder | |
CN104251889A (en) | Method for determining content of three components comprising phenylephrine hydrochloride, chlorphenamine maleate and ibuprofen in compound cold treatment tablet | |
CN108037221B (en) | Method for simultaneously separating and determining methionine sulfoxide and methionine sulfone impurities in compound amino acid injection 18AA by liquid chromatography | |
CN111307975A (en) | Detection method of 8 amino acids in mouse cortex | |
CN118746629A (en) | An analytical method for detecting related substances of fluticasone propionate intermediate thiocarboxylic acid | |
CN107957467A (en) | A kind of method of lysophosphatidyl choline in separation determination pharmaceutical preparation | |
CN115236255B (en) | Method for detecting related substances of loxoprofen sodium | |
CN111380978B (en) | Method for simultaneously determining contents of coenzymes NADP and FAD in medicine | |
CN112697934A (en) | Method for detecting content of pyroglutamic acid in compound amino acid injection | |
CN114778711A (en) | A kind of sulfadoxine related substance analysis method | |
CN109884195A (en) | The method of separating and assaying of Lomefloxacin isomers in a kind of aspartic acid laumosaren | |
CN112595793B (en) | Earthworm injection detection method based on phenol determination | |
Atila Karaca et al. | Development of a sensitive and quantitative HPLC‐FLD method for the determination of obestatin in human plasma | |
CN115372489B (en) | Detection method of tizanidine hydrochloride related substances | |
CN112394112B (en) | Method for detecting content of hydroxychloroquine oxynitride impurities in hydroxychloroquine sulfate | |
CN116593621A (en) | A method for quantitative analysis of drugs in plasma samples using high performance liquid chromatography-tandem mass spectrometry | |
CN118033010A (en) | A detection method and application of flumazenil-related substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20201117 |
|
CF01 | Termination of patent right due to non-payment of annual fee |